Everything You Need to Know About the Vijaya Diagnostic Centre IPO

Vijaya Diagnostic’s IPO opens for subscription on 1st September. The entire public offer comprises an offer for sale of 3.57 crore equity shares aggregating up to Rs. 1,895 crores.

About the company:

Vijaya Diagnostic Centre Ltd. is the largest integrated diagnostic chain in southern India, by operating revenue, and also one of the fastest-growing diagnostic chains by revenue for the fiscal year 2020. The company offers a one-stop solution for pathology and radiology testing services through its extensive operational network, which consists of 81 diagnostic centers and 11 reference laboratories across 13 cities and towns in the states of Telangana and Andhra Pradesh, and the National Capital Region and Kolkata as on June 30, 2021.

Financial Snapshot:

Financial Year Ended Revenue (₹ Crores) PAT (₹ Crores) EPS (₹)
March 2019 302.94 46.27 4.5
March 2020 354.18 62.51 6.13
March 2021 388.59 84.91 8.26
Three months ended June 2020 53.99 1.81 0.19
Three months ended June 2021 125.97 33.33 3.23

IPO Details

Issue Period 1st September 2021 to 3rd September 2021
Price Range ₹ 522 to 531
Minimum Bid Quantity 28 and in multiples thereof
Finalisation of Allotment 8th September 2021
Initiation of Refunds 9th September 2021
Credit of Shares 13th September 2021
Listing Date 14th September 2021
Mandate end Date To Be Confirmed

How do I apply to the Vijaya Diagnostic Centre IPO?

You can apply for the Vijaya Diagnostic Centre IPO using any supported UPI app by following two steps:

  • Enter your bid on Console

  • Accept UPI mandate on your phone

On acceptance of the mandate, the bid amount will get blocked in your bank account. Click hereto learn more.

Where do I check the allotment status for Vijaya Diagnostic IPO?

You can check the allotment status for the Vijaya Diagnostic IPO on the website of the Registrar and Transfer agent.

Alternatively, you can also check the allotment status on the NSE website. The tentative date of allotment is 8th September 2021.